Disseminated intravascular coagulation (DIC) and thrombotic thrombocytopenic purpura (TTP) are different disease states, while ADAMTS13 deficiency could occur in sepsis-induced DIC. We report 2 patients who had septic DIC with features of idiopathic TTP characterized by low ADAMTS13 activity and positive ADAMTS13 inhibitor. They had a specific fulminant course and fatal outcome, which might represent a new specific syndrome.
Nguyen TC, Carcillo JABench-to-bedside review: thrombocytopenia-associated multiple organ failure-a newly appreciated syndrome in the critically ill. Crit Care . 2006;10(6):235.
2.
Dalainas I.Pathogenesis, diagnosis, and management of disseminated intravascular coagulation: a literature review. Eur Rev Med Pharmacol Sci.2008;12(1):19.
3.
Tsai HMAdvances in the pathogenesis, diagnosis, and treatment of thrombotic thrombocytopenic purpura. J Am Soc Nephrol. 2003;14(4):1072.
4.
Rocha E., Paramo JA, Montes R., et al. Acute generalized, widespread bleeding, diagnosis and management . Haematologica. 1998;83(11):1024.
5.
Peyvandi F., Ferrari S., Lavoretano S., et al. von Willebrand factor cleaving protease (ADAMTS-13) and ADAMTS-13 neutralizing autoantibodies in 100 patients with thrombotic thrombocytopenic purpura. Br J Haematol. 2004;127(4):433.
6.
Zheng X., Pallera A., Goodnough L., et al. Remission of chronic thrombotic thrombocytopenic purpura after treatment with cyclophosphamide and rituximab. Ann Interm Med. 2003; 138(2):105.
7.
Taylor FB, Toh CH, Hoots WK, et al. Scientific Subcommittee on Disseminated Intravascular Coagulation (DIC) of the International Society on Thrombosis and Haemostasis (ISTH). Toward definition, clinical and laboratory criteria and scoring system for disseminated intravascular coagulation. Thromb Haemost. 2001 ; 86(5):1327.
8.
Cisneros J., Reyes M., Pachón J., et al. Bacteremia due to Acinetobacter baumannii: epidemiology, clinical findings, and prognostic features. Clin Infect Dis. 1996;22(6):1026.
9.
Thom KA, Schweizer ML, Osih RB, et al. Impact of empiric antimicrobial therapy on outcomes in patients with Escherichia coli and Klebsiella pneumoniae bacteremia: a cohort study . BMC Infect Dis. 2008;8:116.
10.
Ono T., Mimuro J., Madoiwa S., et al. Severe secondary deficiency of von Willebrand factor-cleaving protease (ADAMTS13) in patients with sepsis-induced disseminated intravascular coagulation: its correlation with development of renal failure. Blood. 2006;107(2):528-534.
